Linda Pullan

Business Development Consultant, founder at Pullan Consulting

Speaker

Dr. Linda Pullan is the founder of Pullan Consulting, which helps in all aspects of business development for fund raising and partnering, including outreach, evaluation, valuation, negotiation and strategy. Linda and her team have an extensive deal sheet from company acquisitions to Phase III to preclinical candidates to technologies, with deals and clients in the US, Europe, and Asia.

After a Ph.D. in Biochemistry, Linda has over 20 years of industry experience, starting in drug discovery at Monsanto/Searle/Pfizer and ICI/Zeneca/AstraZeneca. She led teams that put Seroquel, a multi-billion-dollar antipsychotic, and other molecules into development. Business development began with in-licensing technology and early drug candidates at AstraZeneca and continued as head of oncology hematology licensing for Amgen. She then joined Kosan Biosciences as VP of Business Development, focusing on out-licensing. Now she and her team serve as consultants to a wide array of biotechnology and pharma companies. She has worked on over 100 completed deals. She has taught business development for several companies, served as a grant reviewer for the Australian Medical Research Futures Fund, and has served as an expert witness in licensing litigation. She also served as CEO and on boards for several small companies and for the AUTM Foundation. Linda has spoken at many meetings and published many papers and chapters.

The team at Pullan Consulting writes a free monthly newsletter Pullan’s Pieces (sign up on www.PullanConsulting.com), for thousands of readers. The website also includes links to webinars and whitepapers.